As we embark on year 4 of ULACNet, this issue highlights successes & opportunities, considers how we respond to the community voice in study recruitment, discusses community participation in ULACNet-201 trial recruitment… Learn more
POSTED: 9/23/2022
SOURCE: DCP News
Recruitment has begun for a clinical study that investigators hope will move “liquid biopsy” technology closer to its still-distant goal: a single blood test for the early detection of cancer. Collectively known as multi-… Learn more
POSTED: 9/15/2022
SOURCE: Cancer Prevention Science Blog
Research Highlights are a new type of blog for Cancer Prevention Science, where recent publications are highlighted rather than a traditional news story.
This month’s blog post highlights how a cruciferous… Learn more
This month’s blog post highlights how a cruciferous… Learn more
POSTED: 8/24/2022
SOURCE: Cancer Prevention Science Blog
In 2012, Patricia Ganz, M.D., saw a 39-year-old cancer survivor for a consultation who had a long-term history of anxiety during medical visits. The woman had been diagnosed with Hodgkin lymphoma when she was 23 years old.… Learn more
POSTED: 8/10/2022
SOURCE: Cancer Prevention Science Blog
Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet).
POSTED: 7/22/2022
SOURCE: CP-CTNet DMACC Website
Unlike many other cancers, the incidence and death rates for uterine cancer are rising.
Rates of new uterine cancer cases have risen 0.6% per year from 2010-2019, and death rates have risen an average of 1.7%… Learn more
Rates of new uterine cancer cases have risen 0.6% per year from 2010-2019, and death rates have risen an average of 1.7%… Learn more
POSTED: 6/28/2022
SOURCE: Cancer Prevention Science Blog
National Cancer Institute prevention chief discusses steps toward largest U.S. cancer screening trial ever
POSTED: 6/22/2022
SOURCE: Science Magazine
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) hosted a two-day virtual meeting to discuss aspirin and NSAIDs in cancer prevention and treatment.
The workshop was catalyzed by the… Learn more
The workshop was catalyzed by the… Learn more
POSTED: 6/15/2022
SOURCE: DCP News
In the era of personalized medicine, prevention and screening for breast cancer are evolving toward new approaches that assess each woman’s risk and lifestyle factors. All women do not carry the same risk for the same type… Learn more
POSTED: 5/6/2022
SOURCE: Cancer Prevention Science Blog
In this issue, we feature: ULACNet Initiative to Enhance Community Dialogue, Community outreach strategies for recruitment in ULACNet-101 in Puerto Rico, Accrual initiated in Peru for ULACNet-301, an Investigator Spotlight… Learn more
POSTED: 4/28/2022
SOURCE: DCP News
One of the exciting areas of cancer prevention research is the development of noninvasive tests that may have the potential to easily and accurately determine whether and where in the body a person has early-stage… Learn more
POSTED: 4/21/2022
SOURCE: NCI Cancer Currents Blog
Overall, cancer death rates in the United States have been declining about 2% per year, current SEER data from 2014 through 2018 show. However, these improvements have not been experienced equally by everyone, which is one… Learn more
POSTED: 4/18/2022
SOURCE: Cancer Prevention Science Blog
Joyce Ares had just turned 74 and was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer. After a repeat blood test, a PET… Learn more
POSTED: 4/11/2022
SOURCE: DCP News
April 8-13, 2022
DCP/PREVENT-funded Project Presentations
Session OPO.IM01.01 - Tumor Immunobiology
5631 - Immunomodulatory activity of sulindac plus erlotinib for colon cancer prevention in familial adenomatous polyposis
Presenter/Authors
Chakrapani Tripathi, Roderick H. Dashwood. Texas A&M… Learn more
POSTED: 4/1/2022
SOURCE: DCP News
Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet).
POSTED: 3/31/2022
SOURCE: CP-CTNet DMACC Website
Philadelphia, March 25, 2022 — The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), is more than halfway to its recruiting goal of 128,905 participants with more than 20% of participants in the United States being… Learn more
POSTED: 3/25/2022
SOURCE: ECOG-ACRIN Press Release
This issue of Nutrition Frontiers showcases gut permeability with calcium and/or vitamin D3, microRNAs role in suppressing colitis and inflammation-associated colon cancer, and how dietary spinach reshapes gut microbiome.… Learn more
POSTED: 3/18/2022
SOURCE: DCP News
Tumor cells release telltale molecules into blood, urine, and other bodily fluids. But it can be difficult to detect tumor-derived DNA, RNA, and proteins in the earliest stages of disease, when cancers can be easier to treat… Learn more
POSTED: 2/9/2022
SOURCE: Cancer Prevention Science Blog
While new cases of most cancer types have dropped over the past decade, cases of the most common type of liver cancer, hepatocellular carcinoma (HCC), are on the rise. Until recently, the main cause of HCC was hepatitis C… Learn more
POSTED: 2/4/2022
SOURCE: NCI Cancer Currents Blog
This issue recognizes January as Cervical Cancer Awareness Month by presenting four articles entitled, "ULACNet Annual Meeting: A Global Network Together in One (Zoom) Room", "Perseverance Through the COVID… Learn more
POSTED: 1/28/2022
SOURCE: DCP News
Many people being treated for advanced cancer experience serious financial problems related to the cost of their care, even if they have health insurance, according to a new study.
POSTED: 1/26/2022
SOURCE: NCI Cancer Currents Blog
The Division of Cancer Prevention (DCP) of the National Cancer Institute (NCI) hosted a virtual workshop to obtain information relevant to the potential creation of a new NCI-funded cancer screening clinical trials network… Learn more
POSTED: 1/25/2022
SOURCE: DCP News
A meeting of statistical leads from the seven NCI Community Oncology Research Program (NCORP) Research Bases with statisticians from the Division of Cancer Prevention (DCP) Biometry Research Group took place on July… Learn more
POSTED: 1/20/2022
SOURCE: DCP News
Lung cancer, the leading cause of cancer deaths worldwide killing 1.8 million people each year, is often diagnosed at an advanced stage when the chances for a cure are limited.
In the United States, almost 60… Learn more
In the United States, almost 60… Learn more
POSTED: 1/14/2022
SOURCE: Cancer Prevention Science Blog
Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet).
POSTED: 12/22/2021
SOURCE: CP-CTNet DMACC Website